还是不涨，有什么用_老虎社区_美港股上老虎

woosu
2020-11-10

还是不涨，有什么用

5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的5只价值股</blockquote>

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.

5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的5只价值股</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":305539637,"tweetId":"305539637","gmtCreate":1605009001929,"gmtModify":1703835718726,"author":{"id":3552780443992615,"idStr":"3552780443992615","authorId":3552780443992615,"authorIdStr":"3552780443992615","name":"woosu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>还是不涨，有什么用</p></body></html>","htmlText":"<html><head></head><body><p>还是不涨，有什么用</p></body></html>","text":"还是不涨，有什么用","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/305539637","repostId":2082869701,"repostType":2,"repost":{"id":"2082869701","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1604935821,"share":"https://www.laohu8.com/m/news/2082869701?lang=zh_CN&edition=full","pubTime":"2020-11-09 23:30","market":"hk","language":"en","title":"5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的5只价值股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2082869701","media":"Benzinga","summary":"What are Value Stocks?\n\nA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.","content":"<p><html><body><h1>What are Value Stocks?</h1> A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.</p><p><blockquote><html><body><h1>什么是价值股？</h1>价值股票传统上是根据市场投资者如何评估该公司未来增长前景来定义的。低市盈率是表明公司被低估的良好基础指标，很可能被贴上价值股的标签。</body></html></blockquote></p><p> <h2>Below is a list of notable value stocks in the healthcare sector:</h2> <ol> <li><strong>SELLAS Life Sciences Gr</strong> (NASDAQ:SLS) - P/E: 0.62</li> <li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus Pharmaceuticals</a></strong> (NASDAQ:SUPN) - P/E: 9.78</li> <li><strong>Ocugen</strong> (NASDAQ:OCGN) - P/E: 0.04</li> <li><strong>Oncternal Therapeutics</strong> (NASDAQ:ONCT) - P/E: 4.61</li> <li><strong>Coherus BioSciences</strong> (NASDAQ:CHRS) - P/E: 7.01</li> </ol> SELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote><h2>以下是医疗保健行业值得注意的价值股票列表：</h2><ol><li><strong>塞拉斯生命科学集团</strong>（纳斯达克：SLS）-市盈率：0.62</li><li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus制药公司</a></strong>（纳斯达克：SUPN）-市盈率：9.78</li><li><strong>奥库根</strong>（纳斯达克：OCGN）-市盈率：0.04</li><li><strong>内科治疗学</strong>（纳斯达克：ONCT）-市盈率：4.61</li><li><strong>Coherus生物科学公司</strong>（纳斯达克：CHRS）-市盈率：7.01</li></ol>SELLAS Life Sciences Gr被评为价值股。SELLAS Life Sciences Gr第二季度EPS为-0.66，自上季度（第一季度）以来没有变化。SELLAS Life Sciences Gr没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Supernus Pharmaceuticals公布的每股收益为0.74，而第二季度每股收益为0.65。Supernus Pharmaceuticals没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Ocugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Ocugen公布第三季度每股收益为-0.02，较第二季度-0.19增长89.47%。Ocugen没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Oncternal Therapeutics报告每股收益为-0.22，而第二季度每股收益为-0.34。Oncternal Therapeutics没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Coherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Coherus BioSciences第三季度每股收益为0.47，而第二季度为0.81。Coherus BioSciences没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p><p><blockquote>这5只价值股是Benzinga Insights根据量化分析选出的。虽然这种有条不紊的判断过程并不意味着做出最终决定，但我们的技术可以让投资者对该行业有更多的了解。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的5只价值股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的5只价值股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2020-11-09 23:30</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><body><h1>What are Value Stocks?</h1> A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.</p><p><blockquote><html><body><h1>什么是价值股？</h1>价值股票传统上是根据市场投资者如何评估该公司未来增长前景来定义的。低市盈率是表明公司被低估的良好基础指标，很可能被贴上价值股的标签。</body></html></blockquote></p><p> <h2>Below is a list of notable value stocks in the healthcare sector:</h2> <ol> <li><strong>SELLAS Life Sciences Gr</strong> (NASDAQ:SLS) - P/E: 0.62</li> <li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus Pharmaceuticals</a></strong> (NASDAQ:SUPN) - P/E: 9.78</li> <li><strong>Ocugen</strong> (NASDAQ:OCGN) - P/E: 0.04</li> <li><strong>Oncternal Therapeutics</strong> (NASDAQ:ONCT) - P/E: 4.61</li> <li><strong>Coherus BioSciences</strong> (NASDAQ:CHRS) - P/E: 7.01</li> </ol> SELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote><h2>以下是医疗保健行业值得注意的价值股票列表：</h2><ol><li><strong>塞拉斯生命科学集团</strong>（纳斯达克：SLS）-市盈率：0.62</li><li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus制药公司</a></strong>（纳斯达克：SUPN）-市盈率：9.78</li><li><strong>奥库根</strong>（纳斯达克：OCGN）-市盈率：0.04</li><li><strong>内科治疗学</strong>（纳斯达克：ONCT）-市盈率：4.61</li><li><strong>Coherus生物科学公司</strong>（纳斯达克：CHRS）-市盈率：7.01</li></ol>SELLAS Life Sciences Gr被评为价值股。SELLAS Life Sciences Gr第二季度EPS为-0.66，自上季度（第一季度）以来没有变化。SELLAS Life Sciences Gr没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Supernus Pharmaceuticals公布的每股收益为0.74，而第二季度每股收益为0.65。Supernus Pharmaceuticals没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Ocugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Ocugen公布第三季度每股收益为-0.02，较第二季度-0.19增长89.47%。Ocugen没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Oncternal Therapeutics报告每股收益为-0.22，而第二季度每股收益为-0.34。Oncternal Therapeutics没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Coherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Coherus BioSciences第三季度每股收益为0.47，而第二季度为0.81。Coherus BioSciences没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p><p><blockquote>这5只价值股是Benzinga Insights根据量化分析选出的。虽然这种有条不紊的判断过程并不意味着做出最终决定，但我们的技术可以让投资者对该行业有更多的了解。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen","SLS":"SELLAS Life Sciences Group Inc.","ONCT":"Oncternal Therapeutics, Inc.","SUPN":"Supernus Pharmaceuticals","CHRS":"Coherus Biosciences"},"source_url":"https://www.benzinga.com/node/18273686","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2082869701","content_text":"What are Value Stocks?\nA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.\nBelow is a list of notable value stocks in the healthcare sector:\n\nSELLAS Life Sciences Gr (NASDAQ:SLS) - P/E: 0.62\nSupernus Pharmaceuticals (NASDAQ:SUPN) - P/E: 9.78\nOcugen (NASDAQ:OCGN) - P/E: 0.04\nOncternal Therapeutics (NASDAQ:ONCT) - P/E: 4.61\nCoherus BioSciences (NASDAQ:CHRS) - P/E: 7.01\n\nSELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nOcugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nCoherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nThese 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.","news_type":1,"symbols_score_info":{"CHRS":0.9,"OCGN":0.9,"ONCT":0.9,"SLS":0.9,"SUPN":0.9}},"isVote":1,"tweetType":1,"viewCount":2759,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}